hero section gradient
14 handpicked stocks

Dubai's Flying Taxis

Joby Aviation's successful flights in Dubai are taking air taxis from sci-fi to reality. These carefully selected companies represent the entire urban air mobility ecosystem, from aircraft manufacturers to the technology providers making sky transport possible.

Author avatar

Han Tan | Market Analyst

Published on July 1

Your Basket's Financial Footprint

Interpretation of the basket's market capitalisation and investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility, broader market-like behaviour, and comparatively reduced downside risk.
  • Suitable as a core, long-term holding for diversified portfolios rather than a short-term, speculative trade.
  • Expect steadier, long-term appreciation rather than rapid, explosive gains; growth is likely moderate.
Total Market Cap
  • EVEX: $1.55B

  • EH: $1.30B

  • LILM: $52.19M

  • Other

About This Group of Stocks

1

Our Expert Thinking

Dubai's milestone flight signals that urban air mobility is ready for takeoff as a commercial service. This collection captures the full value chain that will benefit from this transportation revolution – from the companies building the aircraft to those providing the critical technology that keeps them flying.

2

What You Need to Know

This group represents a high-growth sector at a crucial turning point. With Joby's successful flight, the industry is moving from experimental to commercial stage, significantly reducing risks and accelerating the timeline for urban air taxi services worldwide.

3

Why These Stocks

These companies were specifically selected to cover the entire urban air mobility ecosystem. The collection includes pioneering eVTOL manufacturers, their key competitors, and essential suppliers of technologies like advanced avionics, batteries, and network management software.

Why You'll Want to Watch These Stocks

🚀

Early Stages of a Transportation Revolution

You're witnessing the birth of an entirely new transit category. With commercial service launching in Dubai, these companies are at the forefront of what analysts project to be a $1 trillion market by 2040.

🔍

The Overlooked Suppliers

While headlines focus on aircraft manufacturers, many investors miss the essential technology providers in this collection that could see massive growth as the industry scales up.

⏱️

Perfect Timing for Entry

With Joby's successful flight in Dubai, the industry just passed a crucial milestone. This is the inflection point where urban air mobility shifts from experimental to commercial, potentially accelerating growth across the sector.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions